Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-7-2
|
pubmed:abstractText |
Approximately 70 families with familial isolated hyperparathyroidism (FIHP) have been reported. Whether it is a separate entity or a variant of multiple endocrine neoplasia type 1 (MEN1 at 11q13) or hyperparathyroidism-jaw tumor (HPT-JT or HRPT2 at 1q21-32) syndrome is not known. We describe here 3 unreported families with familial primary hyperparathyroidism and evaluate their clinical, pathological, and genetic profiles. Biochemical and radiological screenings for MEN1 were negative for all families. In 2 families with a total of 10 affected cases and 3 female obligate carriers, there is no evidence of jaw or renal lesions despite careful radiological investigations. In both families the disease was linked to the 1q21-q32 region with the maximum logarithm of the odds (lod) scores of 3.10 and 3.43 for markers D1S222 and D1S249 respectively, at recombination fraction of 0. In 1 family 2 types of parathyroid pathology were found: 3 of chief cell type and 1 of oxyphil/oncocytic cell type. Two chief cell tumors and 1 oxyphil tumor were found to have loss of heterozygosity (LOH) involving loss of the wild-type alleles for chromosome 1q markers. In the third family, with 4 affected siblings, a parathyroid carcinoma and 2 cases of polycystic kidney disease were found. The parathyroid carcinoma also showed loss of heterozygosity in the 1q region. In conclusion, we found that the hyperparathyroidism traits in a subset of FIHP families are linked to the 1q21-32 markers in the HRPT2 region. We describe the spectrum of parathyroid disease in 1q-linked families involving 3 different types of pathology and demonstrate for the first time loss of wild-type alleles in these parathyroid tumors. Taken together, the results suggest that some of the FIHP are a variant of HPT-JT and that the gene involved is a tumor suppressor gene.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0021-972X
|
pubmed:author |
pubmed-author:FarneboFF,
pubmed-author:FarneboL OLO,
pubmed-author:GrimeliusLL,
pubmed-author:HöögAA,
pubmed-author:Korpi-HyövältiEE,
pubmed-author:KytöläSS,
pubmed-author:LarssonCC,
pubmed-author:NordenströmJJ,
pubmed-author:RobinsonBB,
pubmed-author:SandelinKK,
pubmed-author:TehB TBT,
pubmed-author:TwiggSS,
pubmed-author:WongF KFK
|
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2114-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9626148-Adult,
pubmed-meshheading:9626148-Alleles,
pubmed-meshheading:9626148-Chromosome Mapping,
pubmed-meshheading:9626148-Chromosomes, Human, Pair 1,
pubmed-meshheading:9626148-Female,
pubmed-meshheading:9626148-Haplotypes,
pubmed-meshheading:9626148-Humans,
pubmed-meshheading:9626148-Hyperparathyroidism,
pubmed-meshheading:9626148-Lod Score,
pubmed-meshheading:9626148-Loss of Heterozygosity,
pubmed-meshheading:9626148-Male,
pubmed-meshheading:9626148-Parathyroid Glands,
pubmed-meshheading:9626148-Parathyroid Neoplasms,
pubmed-meshheading:9626148-Pedigree
|
pubmed:year |
1998
|
pubmed:articleTitle |
Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families.
|
pubmed:affiliation |
Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden. Bin.Teh@cmm.ki.se
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|